🇺🇸 Eziclen in United States

121 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 121

Most-reported reactions

1. Headache — 22 reports (18.18%)
2. Nausea — 18 reports (14.88%)
3. Dizziness — 13 reports (10.74%)
4. Abdominal Pain — 12 reports (9.92%)
5. Malaise — 11 reports (9.09%)
6. Multiple Sclerosis Relapse — 10 reports (8.26%)
7. Vomiting — 10 reports (8.26%)
8. Oropharyngeal Pain — 9 reports (7.44%)
9. Abdominal Distension — 8 reports (6.61%)
10. Anorectal Discomfort — 8 reports (6.61%)

Source database →

Frequently asked questions

Is Eziclen approved in United States?

Eziclen does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Eziclen in United States?

Ipsen is the originator. The local marketing authorisation holder may differ — check the official source linked above.